Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01776307
Title A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

colorectal cancer

Therapies

Cetuximab + Napabucasin

Capecitabine + Napabucasin

Napabucasin + Panitumumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Scottsdale Arizona 85259 United States Details
USOR - Rocky Mountain Cancer Center Denver Colorado 80218 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
USOR - Minnesota Oncology Hematology Minneapolis Minnesota 55404 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
USOR - Northwest Cancer Specialists Portland Oregon 97227 United States Details
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Institute for Translational Oncology Research, Greenville Hospital System Greenville South Carolina 29605 United States Details
USOR - Texas Oncology Dallas Dallas Texas 75246 United States Details
US Oncology Research The Woodlands Texas 77380 United States Details
USOR - Texas Oncology Tyler Tyler Texas 75702 United States Details
USOR - Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field